Lotenol is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, uveitis. Lotenol is also indicated for the treatment of post-operative inflammation following ocular surgery.
Dosage & Administration
Shake well before use. One drop instilled into the affected eye(s) four times daily.
If signs and symptoms fail to improve after two days, the patient should be re-evaluated. If this product is used for 10 days or longer, intraocular pressure should be monitored. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. If redness or itching becomes aggravated, the patient should be advised to consult a physician. Patients who wear soft contact lenses and whose eyes are not red, should be instructed to wait at least ten minutes after instilling Lotenol before they insert their contact lenses.
Use in Pregnancy & Lactation:
Pregnancy: Pregnancy Category C. For Loteprednol Etabonate sterile ophthalmic suspension no clinical data on exposed pregnancies are available. Studies in animals have shown reproductive toxicity. The potential r i s k f o r humans i s unknown and i t should not be used in pregnancy unless clearly necessary.
Lactation: It is not known whether topical ophthalmic administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Caution should be exercised when Lotenol is administered to a nursing woman.